Quick Answer
Propanc Biopharma, Inc. reported Total Assets of $19.63 million for fiscal year 2025.
Propanc Biopharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $19.63M | +27028.9% |
| 2024 | $72.4K | +20.0% |
| 2023 | $60.3K | -26.1% |
| 2022 | $81.7K | +523.2% |
| 2021 | $13.1K | -86.7% |
| 2020 | $98.5K | -3.1% |
| 2019 | $101.7K | +42.4% |
| 2018 | $71.4K | -24.9% |
| 2017 | $95.1K | -74.9% |
| 2016 | $379.1K | -39.5% |
| 2015 | $627.1K | +451.3% |
| 2014 | $113.7K | +6410.9% |
| 2013 | $1.7K | -96.2% |
| 2012 | $46.3K | -99.6% |
| 2011 | $10.81M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $15.11M | +19142.3% | -15.9% |
| September 30, 2025 | $17.98M | +28144.1% | -8.4% |
| June 30, 2025 | $19.63M | +27028.9% | -12.9% |
| March 31, 2025 | $22.53M | +60235.2% | +28585.2% |
| December 31, 2024 | $78.5K | -67.5% | +23.4% |
| September 30, 2024 | $63.6K | -64.7% | -12.1% |
| June 30, 2024 | $72.4K | +20.0% | +93.8% |
| March 31, 2024 | $37.3K | -74.0% | -84.6% |
- Propanc Biopharma, Inc. showed an increase of +27028.9% in Total Assets compared to the prior fiscal year.
- Over the 2011–2025 period, Propanc Biopharma, Inc.’s total assets has grown by 81.5% (from $10.81 million to $19.63 million).
- The most recent figure is from Propanc Biopharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on September 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: